184 related articles for article (PubMed ID: 34016454)
1. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study.
Sköld C; Bjørge T; Ekbom A; Engeland A; Gissler M; Grotmol T; Madanat-Harjuoja L; Ording AG; Trabert B; Tretli S; Troisi R; Sørensen HT; Glimelius I
Br J Cancer; 2020 Jul; 123(1):161-166. PubMed ID: 32336755
[TBL] [Abstract][Full Text] [Related]
3. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine factors and risk of nonepithelial ovarian cancers.
Sieh W; Sundquist K; Sundquist J; Winkleby MA; Crump C
Gynecol Oncol; 2014 May; 133(2):293-7. PubMed ID: 24530563
[TBL] [Abstract][Full Text] [Related]
5. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I
Int J Cancer; 2022 Mar; 150(5):773-781. PubMed ID: 34648676
[TBL] [Abstract][Full Text] [Related]
6. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group.
Horn-Ross PL; Whittemore AS; Harris R; Itnyre J
Epidemiology; 1992 Nov; 3(6):490-5. PubMed ID: 1329996
[TBL] [Abstract][Full Text] [Related]
7. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers.
Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF
Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358
[TBL] [Abstract][Full Text] [Related]
9. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
10. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
11. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
12. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
13. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for benign serous and mucinous epithelial ovarian tumors.
Jordan SJ; Green AC; Whiteman DC; Webb PM
Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
[TBL] [Abstract][Full Text] [Related]
15. Non-epithelial ovarian cancer in Denmark - Incidence and survival over nearly 40 years.
Bennetsen AKK; Baandrup L; Aalborg GL; Kjaer SK
Gynecol Oncol; 2020 Jun; 157(3):693-699. PubMed ID: 32223987
[TBL] [Abstract][Full Text] [Related]
16. Patterns and progress in ovarian cancer over 14 years.
Chan JK; Cheung MK; Husain A; Teng NN; West D; Whittemore AS; Berek JS; Osann K
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):521-8. PubMed ID: 16946210
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
18. Use of antidepressants and risk of epithelial ovarian cancer.
Mørch LS; Dehlendorff C; Baandrup L; Friis S; Kjaer SK
Int J Cancer; 2017 Dec; 141(11):2197-2203. PubMed ID: 28791695
[TBL] [Abstract][Full Text] [Related]
19. Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989-2015.
van der Hel OL; Timmermans M; van Altena AM; Kruitwagen RFPM; Slangen BFM; Sonke GS; van de Vijver KK; van der Aa MA
Eur J Cancer; 2019 Sep; 118():97-104. PubMed ID: 31326731
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
